Work

CTLA-4+ regulatory T cells are increased in cetuximab treated head and neck cancer patients, suppress NK cell cytotoxicity and correlate with poor prognosis (TUM2P.916)

Year: 2014

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.192.supp.71.40

Authors: Hyun-Bae Jie, Patrick Schuler, Steve Lee, Raghvendra Srivastava, Athanassios Argiris, Soldano Ferrone, Theresa Whiteside, Robert Ferris

Institutions: University of Pittsburgh, University of Duisburg-Essen, The University of Texas at San Antonio Health Science Center, Massachusetts General Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1513818792

Cites:

Cited by:

Related to: 10